Meet Dr. Jufeng Wang
Dr. Jufeng Wang has his mother to thank for two things—for becoming a scientist and a good cook. But we’ll get to cooking later.
Jufeng, Pharmaron’s Senior Vice President of Safety Assessment, can’t remember a time when science wasn’t a part of his life. His parents, both doctors, were a strong influence. From reading their medical textbooks as a kid, to observing his mother interact with patients at the hospital, he saw first-hand the importance of medical science to everyday life. He chose medical school for his college education. Pharmacological experiments caught his interest and he completed Master’s and Ph.D. degrees in pharmacology.
During a post-doc in Boston at Beth Israel Deaconess Medical Center, Harvard Medical School as an NIH-supported research associate, Jufeng had an eye-opening experience working on cardiac toxicity resulting from drug abuse. His research work demonstrated a mechanism for sympathetic nerve toxicity due to cocaine abuse. His results suggested a clinical treatment strategy for drug abuse. Jufeng received the Young Investigator Award from the American College of Cardiology in 2001 as a result of his research. From this experience, he recognized the importance of drug safety issues and this interest has continued to be a driving force in his career.
Prior to Pharmaron, Jufeng played an important role in the technical review of preclinical safety drug evaluations and GLP guidelines at the China Food & Drug Administration. His team evaluated over a hundred new chemical entities, biologics, and traditional Chinese medicines. In addition, he led a team that developed new methods for evaluating potential drug toxicity, especially related to cardiovascular risk.
Since joining Pharmaron in 2016, he has been applying his international experience from both China and the US in the GLP regulatory environment to strengthen Pharmaron’s leading position in safety assessment services.
About Dr. Jufeng Wang
Dr. Jufeng Wang joined Pharmaron in 2016 as Senior Vice President, Safety Assessment. Prior to Pharmaron he held a position of Director of National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, CFDA, in China for five years. Dr. Wang received his Ph.D. at the Academy of Military Medical Sciences, China, followed by post-doctoral training at Harvard Medical School. He worked at several US pharmaceutical companies and is an author/co-author of 81 publications and book chapters. He is a deputy vice president of the China Safety Pharmacology Society.
In his spare time, he enjoys cooking. Starting from childhood, he always stayed in kitchen and watched his grandmother and mother cook, and read cooking books bought by using gift money from his parents at Chinese Lunar New Year. His specialty dishes are a combination of Jiangxi (spicy) and Guangdong (sweet) styles.
Updated August 2021
Learn more about Pharmaron’s safety assessment services
